Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ABSI | +240.40% | +18.33% | +35.93% | +25.18% | +66.62% | +144.44% | +170.00% | +873.77% | −16.92% | −44.97% |
| ES-GENOME | +77.68% | +7.17% | +10.73% | +1.36% | +40.10% | +75.18% | +67.22% | +103.26% | −40.74% | −47.14% |
| BCAP-XHEALTH | +20.18% | +1.90% | +5.53% | +0.43% | +6.60% | +23.32% | +15.56% | +26.68% | −28.58% | −33.09% |
| TGENOME | +71.74% | +7.65% | +11.05% | +2.74% | +38.71% | +68.66% | +66.81% | +108.03% | −40.86% | −47.69% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes ABSI: money market or bond funds, or no holdings data yet
| ES-GENOME | TGENOME | |
|---|---|---|
| Held by both | ||
 Twist Bioscience | 10.83% | 8.90% |
 10x Genomics | 10.50% | 7.84% |
 Tempus AI | 9.36% | 6.99% |
 CRISPR Therapeutics | 5.49% | 4.10% |
 Absci | 5.30% | 3.96% |
 Natera | 4.75% | 3.92% |
| Personalis | 5.12% | 3.82% |
 Illumina | 4.71% | 3.80% |
 Guardant Health | 4.83% | 3.61% |
 CareDx | 4.55% | 3.40% |
30 Dec 2025 → 28 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| ABSI | +240.40% | 106.01% | 2.27 |
| ES-GENOME | +77.68% | 42.00% | 1.85 |
| TGENOME | +71.74% | 39.73% | 1.81 |
| BCAP-XHEALTH | +20.18% | 19.56% | 1.03 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | ABSI | ES-GENOME | BCAP-XHEALTH | TGENOME |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 222 million | 470 million | 1,343 million |
| Inception date | N/A | 23 Mar 2021 | 14 May 2021 | 13 Jan 2021 |
| Master fund | N/A | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | กองทุนที่ลงทุนหลายกอง | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 6 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 79.06% | N/A | 84.93% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1 THB | 500 THB | 1,000 THB |
| Subsequent purchase | N/A | 1 THB | 500 THB | 1,000 THB |
| Redemption (amount) | N/A | 1 THB | No minimum | No minimum |
| Redemption (units) | N/A | 1 units | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | No minimum | No minimum |
| Balance (units) | N/A | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+3 | T+3 |
